Section 10400.5 - Mucorhicin Agent for Treatment of Cancer(a) As used in this section, Mucorhicin means that agent, consisting of a mold substrate containing generic forms of Mucor, Rhizopus and various strains of penicillium, as described and defined in the report entitled REPORT, FINDINGS, AND RECOMMENDATIONS of the CALIFORNIA CANCER ADVISORY COUNCIL to DIRECTOR, CALIFORNIA STATE DEPARTMENT OF PUBLIC HEALTH, 2151 Berkeley Way, Berkeley 4, California, with respect to THE TREATMENT OF CANCER WITH MUCORHICIN, dated April 17, 1963.(b) Except as otherwise provided in Section 1708 of the Health and Safety Code the prescription, administration, sale or other distribution of Mucorhicin, as defined in subsection (a) of this section, or any agent substantially similar thereto, in any dosage or guise whatever, in the diagnosis, alleviation, treatment or cure of cancer, or for the treatment of any patient who has or who believes that he or she has or who may have cancer is prohibited.(c) No person shall, for the purpose of prescribing, administering, selling or otherwise distributing Mucorhicin, make any representation that Mucorhicin in any dosage or in any guise whatever, has any value in arresting, alleviating or curing cancer.Cal. Code Regs. Tit. 17, § 10400.5
1. New section filed 10-3-63; effective thirtieth day thereafter (Register 63, No. 17).
2. Amendment filed 12-17-85; effective thirtieth day thereafter (Register 85, No. 51). Note: Authority cited: Sections 208 and 1704, Health and Safety Code. Reference: Section 1704, Health and Safety Code.
1. New section filed 10-3-63; effective thirtieth day thereafter (Register 63, No. 17).
2. Amendment filed 12-17-85; effective thirtieth day thereafter (Register 85, No. 51).